Page last updated: 2024-08-21

fluorobenzenes and Genetic Predisposition

fluorobenzenes has been researched along with Genetic Predisposition in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, M; Tomlinson, B	1
Al-Abri, A; Al-Dhuhli, H; Al-Hashmi, K; Al-Hinai, AT; Al-Rasadi, K; Al-Sabti, H; Al-Waili, K; Al-Yaarubi, S; Al-Zakwani, I; Banerjee, Y	1

Other Studies

2 other study(ies) available for fluorobenzenes and Genetic Predisposition

Article	Year
Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia. Atherosclerosis, 2012, Volume: 223, Issue:2 Topics: Adult; Aged; Analysis of Variance; Asian People; Bilirubin; Biomarkers; China; Female; Fluorobenzenes; Genetic Predisposition to Disease; Glucuronosyltransferase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver-Specific Organic Anion Transporter 1; Male; Medication Adherence; Middle Aged; Organic Anion Transporters; Phenotype; Polymorphism, Genetic; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome; Up-Regulation	2012
First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene. Angiology, 2013, Volume: 64, Issue:4 Topics: Achilles Tendon; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Biomarkers; Blood Component Removal; Carotid Artery Diseases; Carotid Intima-Media Thickness; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; DNA Mutational Analysis; Drug Combinations; Exons; Eye Diseases; Ezetimibe; Female; Fluorobenzenes; Frameshift Mutation; Genetic Predisposition to Disease; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Oman; Pedigree; Phenotype; Pyrimidines; Receptors, LDL; Rosuvastatin Calcium; Sequence Deletion; Sulfonamides; Treatment Outcome; Triglycerides; Xanthomatosis	2013

Article

Year

Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia.

Atherosclerosis, 2012, Volume: 223, Issue:2

Topics: Adult; Aged; Analysis of Variance; Asian People; Bilirubin; Biomarkers; China; Female; Fluorobenzenes; Genetic Predisposition to Disease; Glucuronosyltransferase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver-Specific Organic Anion Transporter 1; Male; Medication Adherence; Middle Aged; Organic Anion Transporters; Phenotype; Polymorphism, Genetic; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome; Up-Regulation

2012

First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.

Angiology, 2013, Volume: 64, Issue:4

Topics: Achilles Tendon; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Biomarkers; Blood Component Removal; Carotid Artery Diseases; Carotid Intima-Media Thickness; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; DNA Mutational Analysis; Drug Combinations; Exons; Eye Diseases; Ezetimibe; Female; Fluorobenzenes; Frameshift Mutation; Genetic Predisposition to Disease; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Oman; Pedigree; Phenotype; Pyrimidines; Receptors, LDL; Rosuvastatin Calcium; Sequence Deletion; Sulfonamides; Treatment Outcome; Triglycerides; Xanthomatosis

2013